Neuronox® Siax® Botulift® Cunox® and Meditoxin®
- Botulinum toxin
- History
Glabellar frown lines
Product Information
Product Information

Composition Active ingredient :Clostridium botulinum toxin type A
Stabilizer: Human serum albumin
Isotonic agent: Sodium chloride

Description It appears as a lyophilized white powder for injection in a colorless transparent vial


Neuronox is indicated for the treatment of benign essential blepharospasm in patients 18 years of age and above
Neuronox is indicated for the treatment of equinus foot deformity due to spasticity in pediatric cerebral palsy patients 2 years of age and above
Temporary improvement of serious glabellar wrinkles ranging from moderate to severe associated with corrugators muscle and/or procerus muscle activities in adults over the age of 18 and below the age of 65


[ Warnings ] since the active constituent in this drug is Clostridium botulinum toxin A neurotoxin which is derived from Clostridium botulinum, the recommended dosages and frequency of administration should be observed with a full understanding of the precautions in use. Physicians administering the drug must understand the relevant neuromuscular anatomy of the area involved and any alterations to the anatomy due to prior surgical procedures. An understanding of standard electromyographic techniques is also required for the administration of the drug. The recommended dosage and frequency of administration for Neuronox should not be exceeded.
[ Neuronox must not be administered to the following patients ] - patients with hypersensitivity reactions to any ingredients of Neuronox - Patients with systemic neuromuscular junctional disorders - Women who are pregnant or may be pregrant and nursing mothers

Medytox Mini Poll

Which area do your patients most want to be treated with Neuronox?
a. Glabellar lines
b. Crow’s feet
c. Forehead lines
d. Masseter
e. Calf
MoreMedytox News